Sanofi to Acquire Dynavax, Adding Vaccines to Pipeline
Dynavax stockholders to receive $15.50 in cash, a 39% premium to Dynavax closing share price on December 23, 2025 Sanofi announced today that it has...
Category : Healthcare and Pharmaceutical
WuXi Biologics Wins Hong Kong ESG Reporting Award
WuXi Biologics (2269.HK) has once again raised the bar for sustainability commitment and transparency. The company has been honored by the Hong Kong ESG Reporting Awards...
Americans Face Health Insurance Rate Hikes
Millions of Americans are facing sticker shock when they look to enroll in their ACA health insurance plan for 2026. An analysis by KFF found that the average...
Bonsai Health Partners with AAD to Advance AI Practice Automation
Bonsai Health, the healthcare technology company building an AI platform to automate complex front office workflows, today announced a strategic partnership with the American Academy...
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx
Proposed acquisition will add new anatomic pathology services, proprietary PCR tests and a national client base Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”), a technology-based company...
Northwell to Launch Long Island’s First Pancreas Transplant
Northwell Transplant Institute is one of 59 adult transplant centers in the U.S. to offer heart, kidney, liver, lung and pancreas programs Northwell Health has received...
Hope Biosciences Reports Promising Phase II Parkinson’s Trial
Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical trial to evaluate Hope Biosciences’ allogeneic adipose‑derived mesenchymal...
Celltrion Gets Positive CHMP Opinion for SteQeyma™ Autoinjector
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion...
Mondego Bio Selects PTPN2 Inhibitor, Targets First Trials in 2026
Mondego Bio, a clinical-stage biotechnology company developing next-generation small-molecule immuno-oncology therapies, today announced the formal selection of its lead clinical candidate, ZE00-0388, a highly selective...
Menarini announces CELLSEARCH® CTC biomarker analysis results
The secondary analysis of the PACE trial highlights the value of counting Circulating Tumor Cells (CTCs) in the blood to help guide treatment escalation or...
AusperBio Completes Phase III AUSHINE Study Patient Enrollment
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company developing targeted oligonucleotide therapies for functional cure of chronic hepatitis B (CHB), today announced the completion...
Samsung Biologics expands U.S. manufacturing with GSK acquisition
Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered...
Syremis Therapeutics Raises $165M for Mental Health Drugs
Addressing major unmet needs in mental health with pharmacology rooted in emerging and clinically validated neuropsychiatric biology Lead program ST-905, a potent M1/M4 muscarinic agonist,...
AtomVie Secures Supply Deal with Ionetix for Ac-225 Drugs
AtomVie Global Radiopharma (AtomVie), a global radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in GMP manufacturing and clinical supply, is pleased to announce a...
CISCRP Launches Interactive Dashboard for Clinical Research
The Center for Information and Study on Clinical Research Participation (CISCRP) has launched an interactive data dashboard, giving clinical research stakeholders customized access to data...